These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 23688866)

  • 1. Effects of cilnidipine on sympathetic outflow and sympathetic arterial pressure and heart rate regulations in rats.
    Yamamoto H; Kawada T; Shimizu S; Kamiya A; Miyazaki S; Sugimachi M
    Life Sci; 2013 Jul; 92(24-26):1202-7. PubMed ID: 23688866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute effects of intravenous nifedipine or azelnidipine on open-loop baroreflex static characteristics in rats.
    Yamamoto H; Kawada T; Shimizu S; Kamiya A; Turner MJ; Miyazaki S; Sugimachi M
    Life Sci; 2015 Apr; 126():37-41. PubMed ID: 25707754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The evaluation of the N-type channel blocking properties of cilnidipine and other voltage-dependent calcium antagonists.
    Nap A; Mathy MJ; Balt JC; Pfaffendorf M; van Zwieten PA
    Fundam Clin Pharmacol; 2004 Jun; 18(3):309-19. PubMed ID: 15147282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cilnidipine inhibits the sympathetic nerve activity and improves baroreflex sensitivity in patients with hypertension.
    Kishi T; Hirooka Y; Konno S; Sunagawa K
    Clin Exp Hypertens; 2009 May; 31(3):241-9. PubMed ID: 19387900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ivabradine does not acutely affect open-loop baroreflex static characteristics and spares sympathetic heart rate control in rats.
    Yamamoto H; Kawada T; Shimizu S; Uemura K; Inagaki M; Kakehi K; Iwanaga Y; Fukuda K; Miyamoto T; Miyazaki S; Sugimachi M
    Int J Cardiol; 2018 Apr; 257():255-261. PubMed ID: 29506704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contrasting effects of moderate vagal stimulation on heart rate and carotid sinus baroreflex-mediated sympathetic arterial pressure regulation in rats.
    Kawada T; Shimizu S; Li M; Kamiya A; Uemura K; Sata Y; Yamamoto H; Sugimachi M
    Life Sci; 2011 Sep; 89(13-14):498-503. PubMed ID: 21855552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cilnidipine, an N+L-type dihydropyridine Ca channel blocker, suppresses the occurrence of ischemia/reperfusion arrhythmia in a rabbit model of myocardial infarction.
    Nagai H; Minatoguchi S; Chen XH; Wang N; Arai M; Uno Y; Lu C; Misao Y; Onogi H; Kobayashi H; Takemura G; Maruyama R; Fujiwara T; Fujiwara H
    Hypertens Res; 2005 Apr; 28(4):361-8. PubMed ID: 16138567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of the L/N-type calcium channel blocker (cilnidipine) on sympathetic hyperactive morning hypertension: results from ACHIEVE-ONE.
    Kario K; Ando S; Kido H; Nariyama J; Takiuchi S; Yagi T; Shimizu T; Eguchi K; Ohno M; Kinoshita O; Yamada T
    J Clin Hypertens (Greenwich); 2013 Feb; 15(2):133-42. PubMed ID: 23339732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic understanding of acute effects of intravenous guanfacine on rat carotid sinus baroreflex-mediated sympathetic arterial pressure regulation.
    Kawada T; Shimizu S; Turner MJ; Fukumitsu M; Yamamoto H; Sugimachi M
    Life Sci; 2016 Mar; 149():72-8. PubMed ID: 26883977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Baroreceptor-mediated activation of sympathetic nerve activity to salivary glands.
    Sabino-Silva R; Ceroni A; Koganezawa T; Michelini LC; Machado UF; Antunes VR
    Physiol Behav; 2012 Oct; 107(3):390-6. PubMed ID: 23022472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Azelnidipine attenuates cardiovascular and sympathetic responses to air-jet stress in genetically hypertensive rats.
    Nakamoto M; Ohya Y; Sakima A; Yamazato M; Takishita S
    Hypertens Res; 2007 Apr; 30(4):359-66. PubMed ID: 17541215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of L- and N-Type Ca Channel Blocker Cilnidipine on Changes in Heart Rate and QT Interval During Dialysis.
    Iida T; Morimoto S; Amari Y; Ando T; Ichihara A
    Kidney Blood Press Res; 2017; 42(5):933-941. PubMed ID: 29166643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Azelnidipine attenuates glomerular damage in Dahl salt-sensitive rats by suppressing sympathetic nerve activity.
    Nagasu H; Satoh M; Fujimoto S; Tomita N; Sasaki T; Kashihara N
    Hypertens Res; 2012 Mar; 35(3):348-55. PubMed ID: 22072106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockade of N-type Ca2+ current by cilnidipine (FRC-8653) in acutely dissociated rat sympathetic neurones.
    Uneyama H; Takahara A; Dohmoto H; Yoshimoto R; Inoue K; Akaike N
    Br J Pharmacol; 1997 Sep; 122(1):37-42. PubMed ID: 9298526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cilnidipine as an agent to lower blood pressure without sympathetic nervous activation as demonstrated by iodine-123 metaiodobenzylguanidine imaging in rat hearts.
    Sakaki T; Naruse H; Masai M; Takahashi K; Ohyanagi M; Iwasaki T; Fukuchi M
    Ann Nucl Med; 2003 Jun; 17(4):321-6. PubMed ID: 12932117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac effects of L/N-type Ca2+ channel blocker cilnidipine in anesthetized dogs.
    Takahara A; Iwasaki H; Nakamura Y; Sugiyama A
    Eur J Pharmacol; 2007 Jun; 565(1-3):166-70. PubMed ID: 17445796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the effects of cilnidipine and amlodipine on ambulatory blood pressure.
    Hoshide S; Kario K; Ishikawa J; Eguchi K; Shimada K
    Hypertens Res; 2005 Dec; 28(12):1003-8. PubMed ID: 16671340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selectivity of dihydropyridines for cardiac L-type and sympathetic N-type Ca2+ channels.
    Uneyama H; Uchida H; Konda T; Yoshimoto R; Akaike N
    Eur J Pharmacol; 1999 May; 373(1):93-100. PubMed ID: 10408255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of a new calcium channel blocker, azelnidipine, on systemic hemodynamics and renal sympathetic nerve activity in spontaneously hypertensive rats.
    Shokoji T; Fujisawa Y; Kiyomoto H; Rahman M; Sun GP; Fan YY; Kimura S; Kohno M; Abe Y; Nishiyama A
    Hypertens Res; 2005 Dec; 28(12):1017-23. PubMed ID: 16671342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. L/N-type calcium channel blocker cilnidipine ameliorates proteinuria and inhibits the renal renin-angiotensin-aldosterone system in deoxycorticosterone acetate-salt hypertensive rats.
    Toba H; Yoshida M; Tojo C; Nakano A; Oshima Y; Kojima Y; Noda K; Wang J; Kobara M; Nakata T
    Hypertens Res; 2011 Apr; 34(4):521-9. PubMed ID: 21270815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.